Confirm
Bolsters team with addition of established biopharma industry leaders in advance of anticipated regulatory approval and commercialization of once-nightly FT218 for narcolepsy
DUBLIN, Ireland, June 02, 2021 (GLOBE NEWSWIRE) Avadel Pharmaceuticals plc ( AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today it has appointed Jeff Cruikshank as Vice President, Sales; Denise Strauss as Vice President, Marketing and New Product Strategy; and Angela Woods as Vice President, People and Culture.
These newly-created roles will continue to build the Company’s capabilities to support the potential approval and commercialization of once-nightly FT218. As Vice President, Sales, Mr. Cruikshank will lead the development of Avadel’s go-to-market customer model including the buildout and deployment of the Company’s patient-focused
Among other things, the document provides for an expansion of cooperation in research and teacher training as well as the exchange of cultural workers, schoolchildren, trainees, students and scientists.
During the talks, Higher Education Minister Richard Lochhead criticised the UK s decision to not take part in the EU exchange program after leaving the EU.
Mr Lochhead hinted that the Declaration of Intent supports intercultural exchange and would help Scotland to continue higher education and research cooperation despite leaving the EU.
The Scottish Higher Education Minister had asked jointly with Welsh counterparts if they could remain part of the student exchange scheme - Erasmus, but Brussels turned their request down.
SNP ministers have pledged to stay aligned to the EU after Tory UK politicians said British participation in Erasmus+ would not be in the interest of UK taxpayers .
| UPDATED: 10:39, Wed, Feb 10, 2021
Link copied
Vaccine: Nicolas Bay criticises EU for ‘looking for scapegoat’ Sign up to receive our rundown of the day s top stories direct to your inbox
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters.
Sometimes they ll include recommendations for other related newsletters or services we offer.
Our Privacy Notice explains more about how we use your data, and your rights.
You can unsubscribe at any time.
The General Secretary of the right-wing National Rally party blasted the European Union s coronavirusvaccine rollout programme which has been held-up in rows with pharmaceutical companies over a lack of supplies. While speaking at the European Parliament s plenary session on Wednesday, Mr Bay confronted the Commission President over the decision to threaten Northern Ireland with the triggering of Article 16 amid what he called an attempt by Eurocrats to pin their vaccin
URSULA von der Leyen s current woes as she struggles to get to grips with the EU s coronavirus vaccine rollout woes are no surprise, given her domestic track record in her native Germany, a former MEP has said.